India Diversifies Crude Oil Sourcing with Increased Reliance on Russia Brazil and Venezuela Shameful Imbalance Youth Benefit Spending Outpaces Job Investment Says Former Minister UK Trade Deficit With US Emerges as Exports Plunge 25 Following Trump Tariffs ColgatePalmolive India Shifts Focus to Premium Oral Care and Digital Execution for Growth South Koreas Galaxy Robot Park Aims to Merge KPop and Robotics to Redefine Entertainment Tourism MENA Leaders Advocate for Holistic Housing Policy Beyond Construction at Baku Forum Ategrity Specialty Insurance Company Holdings ASIC Q1 2026 Earnings EPS Beats Estimates by 22 Shares Edge Higher SharonAI Holdings Inc SHAZ Q1 2026 Earnings Severe EPS Miss Yet Stock Surges 18 as Market Looks Past Losses WTI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Decline ARAY Q1 2026 Earnings EPS Misses Estimates Stock Surges Despite WiderThanExpected Loss Starwood Property Trust Q1 2026 Earnings EPS Misses Estimates as Shares Edge Lower Simulations Plus SLP Q1 2026 Earnings Earnings Beat Drives Positive Market Reaction Tenable Holdings Climbs 145 as Cybersecurity Tailwinds Support Stock Paylocity PCTY Holds Steady Near Resistance Consolidation or Breakout Navient NAVI Edges Higher as Shares Approach Key Resistance Level AAON Inc AAON Shows Resilience Stock Advances 195 on Measured Trading Ceragon Networks CRNT Surges 526 Testing Key Resistance Levels MOB Q4 2025 Earnings Significant EPS Miss Amid Operational Adjustments WD Q1 2026 Earnings EPS Surges Past Estimates with 62 Surprise DCBO Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Stock Slips Slightly AMWD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency PENN Q1 2026 Earnings EPS Misses Estimates as Margins Remain Under Pressure MGTX Q1 2026 Earnings WiderthanExpected Loss Despite Positive Stock Reaction Technical Analysis Highlights Select Stocks Amid Market Weakness German American Bancorp Inc Q1 2026 Earnings EPS Misses Expectations Amid Muted Stock Reaction Allogene Therapeutics ALLO Surges 6 Can the Biotech Reclaim Key Resistance